Targacept, Inc. (NASDAQ: TRGT) is indicated to open higher today after announcing data from its recently completed Phase 2b clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE